These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6265792)

  • 1. 4',6-Dichloroflavan (BW683C), a new anti-rhinovirus compound.
    Bauer DJ; Selway JW; Batchelor JF; Tisdale M; Caldwell IC; Young DA
    Nature; 1981 Jul; 292(5821):369-70. PubMed ID: 6265792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B.
    Tisdale M; Selway JW
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():97-105. PubMed ID: 6092321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of an early stage of rhinovirus replication by dichloroflavan (BW683C).
    Tisdale M; Selway JW
    J Gen Virol; 1983 Apr; 64 (Pt 4)():795-803. PubMed ID: 6300302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.
    Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
    Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
    Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds.
    Ahmad AL; Tyrrell DA
    Antiviral Res; 1986 Jul; 6(4):241-52. PubMed ID: 3017203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-rhinovirus activity of 2-styrylchromones.
    Desideri N; Conti C; Mastromarino P; Mastropaolo F
    Antivir Chem Chemother; 2000 Nov; 11(6):373-81. PubMed ID: 11227995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
    Dewindt B; van Eemeren K; Andries K
    Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant rhinoviruses from the nose of experimentally treated volunteers.
    Dearden C; al-Nakib W; Andries K; Woestenborghs R; Tyrrell DA
    Arch Virol; 1989; 109(1-2):71-81. PubMed ID: 2558631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man.
    Phillpotts RJ; Wallace J; Tyrrell DA; Freestone DS; Shepherd WM
    Arch Virol; 1983; 75(1-2):115-21. PubMed ID: 6338868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of rhinovirus resistant to an antiviral chalcone.
    Ahmad AL; Dowsett AB; Tyrrell DA
    Antiviral Res; 1987 Aug; 8(1):27-39. PubMed ID: 2825590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
    Al-Nakib W; Tyrrell DA
    Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
    Desideri N; Mastromarino P; Conti C
    Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man.
    Al-Nakib W; Willman J; Higgins PG; Tyrrell DA; Shepherd WM; Freestone DS
    Arch Virol; 1987; 92(3-4):255-60. PubMed ID: 3545152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-picornavirus activity of synthetic flavon-3-yl esters.
    Conti C; Mastromarino P; Sgro R; Desideri N
    Antivir Chem Chemother; 1998 Nov; 9(6):511-5. PubMed ID: 9865389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
    Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
    J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-rhinovirus properties of fluoro-substituted flavonoids.
    Conti C; Mastromarino P; Goldoni P; Portalone G; Desideri N
    Antivir Chem Chemother; 2005; 16(4):267-76. PubMed ID: 16130524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomeric separation of substituted flavanoids by LC-DAD.
    Quaglia MG; Desideri N; Bossù E; Melchiorre P; Conti C
    J Pharm Biomed Anal; 1991; 9(10-12):811-5. PubMed ID: 1668301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4'-Hydroxy-3-methoxyflavones with potent antipicornavirus activity.
    De Meyer N; Haemers A; Mishra L; Pandey HK; Pieters LA; Vanden Berghe DA; Vlietinck AJ
    J Med Chem; 1991 Feb; 34(2):736-46. PubMed ID: 1847431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
    Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
    Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.